| Primary |
| Hiv Infection |
42.1% |
| Chronic Obstructive Pulmonary Disease |
21.1% |
| Asthma |
15.8% |
| Type 2 Diabetes Mellitus |
10.5% |
| Dyspnoea |
5.3% |
| Dysthymic Disorder |
5.3% |
|
| Weight Increased |
33.3% |
| Chronic Obstructive Pulmonary Disease |
16.7% |
| Laryngeal Oedema |
16.7% |
| Non-cardiac Chest Pain |
16.7% |
| Wheezing |
16.7% |
|
| Secondary |
| Product Used For Unknown Indication |
50.7% |
| Asthma |
7.4% |
| Suicide Attempt |
7.4% |
| Chronic Obstructive Pulmonary Disease |
5.1% |
| Arrhythmia |
4.4% |
| Autoimmune Disorder |
2.9% |
| Dyspnoea |
2.9% |
| Hypertension |
2.9% |
| Bronchiectasis |
2.2% |
| Hiv Infection |
2.2% |
| Pulmonary Sarcoidosis |
2.2% |
| Atrial Fibrillation |
1.5% |
| Bronchitis |
1.5% |
| Pain |
1.5% |
| Sinusitis |
1.5% |
| Conjunctivitis |
0.7% |
| Constipation |
0.7% |
| Delirium |
0.7% |
| Diabetic Neuropathy |
0.7% |
| Diarrhoea |
0.7% |
|
| Vestibular Disorder |
21.1% |
| Wheezing |
15.8% |
| Adrenal Suppression |
5.3% |
| Drug Abuse |
5.3% |
| Drug Ineffective |
5.3% |
| Drug Toxicity |
5.3% |
| Local Swelling |
5.3% |
| Rectal Haemorrhage |
5.3% |
| Renal Failure Acute |
5.3% |
| Tachycardia |
5.3% |
| Tendonitis |
5.3% |
| Toxicity To Various Agents |
5.3% |
| Urticaria |
5.3% |
| Weight Increased |
5.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.3% |
| Drug Use For Unknown Indication |
13.6% |
| Diabetes Mellitus |
7.5% |
| Rheumatoid Arthritis |
6.1% |
| Hypertension |
4.4% |
| Asthma |
4.1% |
| Atrial Fibrillation |
4.1% |
| Pain |
3.7% |
| Chronic Obstructive Pulmonary Disease |
3.4% |
| Dyspnoea |
3.1% |
| Psoriasis |
2.7% |
| Acute Coronary Syndrome |
2.4% |
| Thrombosis |
2.4% |
| High Density Lipoprotein Decreased |
2.0% |
| Pulmonary Embolism |
1.7% |
| Percutaneous Coronary Intervention |
1.4% |
| Psoriatic Arthropathy |
1.4% |
| Pulmonary Hypertension |
1.4% |
| Small Cell Lung Cancer Extensive Stage |
1.4% |
| Anaemia Of Malignant Disease |
1.0% |
|
| Rectal Haemorrhage |
7.8% |
| Cellulitis |
5.9% |
| Pneumonia |
5.9% |
| Pulmonary Oedema |
5.9% |
| Pyrexia |
5.9% |
| Renal Failure Acute |
5.9% |
| Vision Blurred |
5.9% |
| Visual Disturbance |
5.9% |
| Weight Decreased |
5.9% |
| Wheezing |
5.9% |
| Cardiac Arrest |
3.9% |
| Death |
3.9% |
| Drug Ineffective |
3.9% |
| Gastric Ulcer Haemorrhage |
3.9% |
| Headache |
3.9% |
| Inappropriate Antidiuretic Hormone Secretion |
3.9% |
| Injection Site Haematoma |
3.9% |
| Injection Site Pain |
3.9% |
| Oedema Peripheral |
3.9% |
| Pain |
3.9% |
|
